Using previously curated datasets of liver cancer patients [42], we found that gene sets expressed in hepatocellular carcinoma patients with poorer prognosis become predominantly downregulated in SAMD1 KO HepG2 cells, while genes that are expressed in HCC patients with better survival become upregulated (Figure 2f). This evidence concerns the gene SAMD1 and liver cancer.